<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>BRIGHT&#039;s Cerebral Palsy Cure Project &#187; spinal fusion surger</title>
	<atom:link href="http://cpcure.com/tag/spinal-fusion-surger/feed/" rel="self" type="application/rss+xml" />
	<link>http://cpcure.com</link>
	<description>Leading the way for a Cerebral Palsy Cure</description>
	<lastBuildDate>Wed, 22 Apr 2026 15:38:37 +0000</lastBuildDate>
	<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
	
	<item>
		<title>Cerebral palsy: the whys and hows &#8211; Cerebral Palsy Research</title>
		<link>http://cpcure.com/cerebral-palsy-the-whys-and-hows-cerebral-palsy-research/</link>
		<comments>http://cpcure.com/cerebral-palsy-the-whys-and-hows-cerebral-palsy-research/#comments</comments>
		<pubDate>Wed, 05 Dec 2012 17:20:19 +0000</pubDate>
		<dc:creator><![CDATA[miamane]]></dc:creator>
				<category><![CDATA[Research Posts]]></category>
		<category><![CDATA[achalasia]]></category>
		<category><![CDATA[antidystonic]]></category>
		<category><![CDATA[Botulinum toxin]]></category>
		<category><![CDATA[Botulinum toxin therapy]]></category>
		<category><![CDATA[esophageal spasms]]></category>
		<category><![CDATA[gastroparesis]]></category>
		<category><![CDATA[myiasis]]></category>
		<category><![CDATA[pulmonary function]]></category>
		<category><![CDATA[Scoliosis Surgery]]></category>
		<category><![CDATA[spastic diplegia]]></category>
		<category><![CDATA[spinal fusion surger]]></category>
		<category><![CDATA[treatment antispasticity]]></category>

		<guid isPermaLink="false">http://cpcure.com/?p=262</guid>
		<description><![CDATA[1. Arch Dis Child Educ Pract Ed. 2012 Aug;97(4):122-31. Cerebral palsy: the whys and hows. Fairhurst C. Correspondence to Dr Charlie Fairhurst, Department of Paediatric Neurodisability, Evelina Children&#8217;s Hospital, Guy&#8217;s and Saint Thomas&#8217; Foundation NHS trust, London SE1 9RT, UK; charlie.fairhurst@gstt.nhs.uk. The descriptive term of cerebral palsy encompasses the largest group of childhood movement disorders.]]></description>
				<content:encoded><![CDATA[<p><!--[if gte mso 9]><xml></p>
<p><o:shapedefaults v:ext="edit" spidmax="1026" /></p>
<p></xml><![endif]--><!--[if gte mso 9]><xml></p>
<p><o:shapelayout v:ext="edit"></p>
<p><o:idmap v:ext="edit" data="1" /></p>
<p></o:shapelayout></xml><![endif]--></p>
<div class="WordSection1">
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">1. Arch Dis Child Educ Pract Ed. 2012 Aug;97(4):122-31.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">Cerebral palsy: the whys and hows.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Fairhurst C.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Correspondence to Dr Charlie Fairhurst, Department of Paediatric Neurodisability, Evelina Children&#8217;s Hospital,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Guy&#8217;s and Saint Thomas&#8217; Foundation NHS trust, London SE1 9RT, UK; charlie.fairhurst@gstt.nhs.uk.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">The descriptive term of cerebral palsy encompasses the largest group of childhood movement disorders. Severity</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">and pattern of clinical involvement varies widely dependent on the area of the central nervous system</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">compromised. A multidisciplinary team approach is vital for all the aspects of management to improve function and</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">minimise disability. From a medical viewpoint, there are two pronged approaches. First a focus on developmental</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">and clinical comorbidities such as communication, behaviour, epilepsy, feeding problems, gastro-oesophageal</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">reflux and infections; and second on specifics of muscle tone, motor control and posture. With regards to the latter,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">there is an increasing number of available treatments including oral antispasticity and antidystonic medications,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">injectable botulinum toxin, multilevel orthopaedic and neurosurgical options and a variety of complementary and</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">alternative therapies.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #009400;">PMID: 22868578 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - in process]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">2. Assist Technol. 2012 Summer;24(2):78-86.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">Wheelchair components and pulmonary function in children with cerebral palsy.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Barks L, Davenport P.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">VA HSR&amp;D/RR&amp;D Research Center of Excellence, Tampa, FL 33544, USA. Lelia.Barks@va.gov</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">OBJECTIVE: This study investigates the effects of four individual wheelchair components (upper extremity</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">supports, lateral trunk supports, anterior pelvic belt, and 30 degree posterior seat tilt), on pulmonary function in</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">prepubertal children with cerebral palsy (CP). METHODS: Participants who range in age from 5-10 years were</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">evaluated using four wheelchair components in six configurations (conditions 1-6) using a planar seating simulator.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">The Respironics Non Invasive Cardiac Output monitor (NICO) and MasterScreen Impulse Oscillometry System</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">(IOS) measured pulmonary function parameters. Repeated measures ANOVA was used to analyze effect of</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 12.0pt; font-family: 'Arial','sans-serif'; color: #333333;">Monday 13 August 2012</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: black;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 18.0pt; font-family: 'Arial,Bold','sans-serif'; color: #2ebb00;">Interventions and Management</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: #333333;">Cerebral Palsy Alliance </span></strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #333333;">is delighted to bring you this free weekly bulletin of the latest published research into</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #333333;">cerebral palsy.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #333333;">Our organisation is committed to supporting cerebral palsy research worldwide &#8211; through information,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #333333;">education, collaboration and funding. This free weekly bulletin is just one of our activities. Please find out more</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #333333;">at </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #009400;">www.cpresearch.org.au</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: #333333;">Professor Nadia Badawi</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #333333;">Macquarie Group Foundation Chair of Cerebral Palsy</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #333333;">PO Box 560, Darlinghurst, New South Wales 2010 Australia</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial,Bold','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">2</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">wheelchair conditions on total airway resistance (R(AW)). RESULTS: Eight participants completed the protocol. R</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">(AW) and minute ventilation (MV) varied with wheelchair condition. Lowest R(AW) was seen with two upper</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">extremity supports or two lateral trunk supports. Differences were not significant (p = 0.253). CONCLUSIONS: The</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">NICO and IOS, independent of participant effort, measured R(AW) and MV, which varied by wheelchair seating</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">condition. More research is needed with a larger sample to determine seating components&#8217; impact on pulmonary</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">function. These methods objectively measured pulmonary function of young children with CP in wheelchairs and</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">could facilitate further research into benefits of wheelchair postural support components.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #009400;">PMID: 22876730 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - in process]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">3. BMC Pediatr. 2012 Aug 9;12(1):120. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">Evaluation of the effects of Botulinum toxin A injections when used to improve ease of care and comfort in</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">children with cerebral palsy whom are non-ambulant: a double blind randomized controlled trial.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Thorley M, Donaghey S, Edwards P, Copeland L, Kentish M, McLennan K, Lindsley J, Gascoigne-Pees L,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Sakzewski L, Boyd</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">BACKGROUND: Children with cerebral palsy (CP) whom are non-ambulant are at risk of reduced quality of life and</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">poor health status. Severe spasticity leads to discomfort and pain. Carer burden for families is significant. This</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">study aims to determine whether intramuscular injections of Botulinum Toxin A (BoNT-A) combined with a regime of</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">standard therapy has a positive effect on care and comfort for children with CP whom are non-ambulant (GMFCS</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">IV/V), compared with standard therapy alone (cycle I), and whether repeated injections with the same regime of</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">adjunctive therapy results in greater benefits compared with a single injecting episode (cycle II). The regime of</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">therapy will include serial casting, splinting and/or provision of orthoses, as indicated, combined with four sessions</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">of goal directed occupational therapy or physiotherapy. Method/design This study is a double blind randomized</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">controlled trial. Forty participants will be recruited. In cycle I, participants will be randomized to either a treatment</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">group who will receive BoNT-A injections into selected upper and/or lower limb muscles, or a control group who will</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">undergo sham injections. Both groups will receive occupational therapy and /or physiotherapy following injections.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Groups will be assessed at baseline then compared at 4 and 16 weeks following injections or sham control.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Parents, treating clinicians and assessors will be masked to group allocation. In cycle II, all participants will undergo</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">intramuscular BoNT-A injections to selected upper and/or lower limb muscles, followed by therapy. The primary</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">outcome measure will be change in parent ratings in identified areas of concern for their child&#8217;s care and comfort,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">using the Canadian Occupational Performance Measure (COPM). Secondary measures will include the Care and</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Comfort Hypertonicity Scale (ease of care), the Cerebral Palsy Quality of Life Questionnaire (CP QoL-Child) (quality</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">of life), the Caregiver Priorities and Child Health Index of Life with Disabilities Questionnaire (CPCHILD(c)) (health</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">status) and the Paediatric Pain Profile (PPP) (pain). Adverse events will be carefully monitored by a clinician</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">masked to group allocation. DISCUSSION: This paper outlines the theoretical basis, study hypotheses and</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">outcome measures for a trial of BoNT-A injections and therapy for children with non-ambulant cerebral palsy. Trial</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">registration Australia New Zealand Clinical Trials Registry:N12609000360213.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #009400;">PMID: 22873758 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">4. Gait Posture. 2012 Aug 4. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">Differences in implementation of gait analysis recommendations based on affiliation with a gait laboratory.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Wren TA, Elihu KJ, Mansour S, Rethlefsen SA, Ryan DD, Smith ML, Kay RM.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Children&#8217;s Orthopaedic Center, Children&#8217;s Hospital Los Angeles, Los Angeles, CA, United States; Keck School of</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Medicine, University of Southern California, Los Angeles, CA, United States.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">This study examined the extent to which gait analysis recommendations are followed by orthopedic surgeons with</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">varying degrees of affiliation with the gait laboratory. Surgical data were retrospectively examined for 95 patients</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">with cerebral palsy who underwent lower extremity orthopedic surgery following gait analysis. Thirty-three patients</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">were referred by two surgeons directly affiliated with the gait laboratory (direct affiliation), 44 were referred by five</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">surgeons from the same institution but not directly affiliated with the gait laboratory (institutional affiliation), and 18</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">were referred by 10 surgeons from other institutions (no affiliation). Data on specific surgeries were collected from</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ Monday 13 August 2012</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial,Bold','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">3</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">the gait analysis referral, gait analysis report, and operative notes. Adherence to the gait analysis recommendations</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">was calculated by dividing the number of procedures where the surgery followed the gait analysis recommendation</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">(numerator) by the total number of procedures initially planned, recommended by gait analysis, or done</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">(denominator). Adherence with the gait analysis recommendations was 97%, 94%, and 77% for the direct,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">institutional, and no affiliation groups, respectively. Procedures recommended for additions to the surgical plan</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">were added 98%, 87%, and 77% of the time. Procedures recommended for elimination were dropped 100%, 89%,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">and 88% of the time. Of 81 patients who had specific surgical plans prior to gait analysis, changes were</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">implemented in 84% (68/81) following gait analysis recommendations. Gait analysis influences the treatment</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">decisions of surgeons regardless of affiliation with the gait laboratory, although the influence is stronger for</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">surgeons who practice within the same institution as the gait laboratory.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Copyright © 2012 Elsevier B.V. All rights reserved.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #009400;">PMID: 22871237 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">5. Hip Int. 2012 Aug 7:0. doi: 10.5301/HIP.2012.9453. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">Hip flexion deformity improves without psoas-lengthening after surgical correction of fixed knee flexion</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">deformity in spastic diplegia.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Rutz E, Gaston MS, Tirosh O, Brunner R.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Paediatric Orthopaedic Department, University Children&#8217;s Hospital Basle, Basle &#8211; Switzerland; and Murdoch</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Children&#8217;s Research Institute, The Royal Children&#8217;s Hospital, Victoria &#8211; Australia.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Background: It is unclear if psoas lengthening surgery is required in the treatment of patients with cerebral palsy</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">(CP) with hip flexion deformity and previous studies show equivocal results with regard to functional outcome.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Methods: This study retrospectively assessed 12 patients with a diagnosis of spastic diplegia who underwent single</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">event multilevel surgery in order to correct deformities in the sagittal plane distal to the hip. Both clinical and</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">instrument gait analysis results were recorded preoperatively, at one year (short term) and at five years (mid term)</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">postoperatively. Results: Clinically measured hip and knee movement improved at both short and mid term follow</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">up. Correlations of clinically measured maximum hip and knee extension were significant at all three time points.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Angles at terminal stance/toe off for hip and knee from kinematic data also showed significant correlations at all</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">three time points. Conclusions: Our study demonstrates that the hip flexion deformities encountered in these</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">patients will improve spontaneously when the distal fixed knee flexion deformity is surgically corrected. Therefore</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">correction at the knee allows the ground reaction force to assume a more normal position resulting in correction at</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">the hip over time. This then removes the need for surgery at the hip level. This fact is especially important when</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">applied to psoas lengthening as this procedure can cause significant reduction in propulsion power.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #009400;">PMID: 22878968 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">6. J Biomech. 2012 Aug 3. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">Medial gastrocnemius muscle fascicle active torque-length and Achilles tendon properties in young adults</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">with spastic cerebral palsy.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Barber L, Barrett R, Lichtwark G.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">School of Physiotherapy and Exercise Science &amp; Centre for Musculoskeletal Research, Griffith University, Gold</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Coast campus, Queensland 4222, Australia.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Individuals with spastic cerebral palsy (CP) typically experience muscle weakness. The mechanisms responsible</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">for muscle weakness in spastic CP are complex and may be influenced by the intrinsic mechanical properties of the</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">muscle and tendon. The purpose of this study was to investigate the medial gastrocnemius (MG) muscle fascicle</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">active torque-length and Achilles tendon properties in young adults with spastic CP. Nine relatively high functioning</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">young adults with spastic CP (GMFCS I, 17±2 years) and 10 typically developing individuals (18±2 years)</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">participated in the study. Active MG torque-length and Achilles tendon properties were assessed under controlled</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">conditions on a dynamometer. EMG was recorded from leg muscles and ultrasound was used to measure MG</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ Monday 13 August 2012</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial,Bold','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">4</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">fascicle length and Achilles tendon length during maximal isometric contractions at five ankle angles throughout the</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">available range of motion and during passive rotations imposed by the dynamometer. Compared to the typically</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">developing group, the spastic CP group had 33% lower active ankle plantarflexion torque across the available</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">range of ankle joint motion, partially explained by 37% smaller MG muscle and 4% greater antagonistic cocontraction.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">The Achilles tendon slack length was also 10% longer in the spastic CP group. This study confirms</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">young adults with mild spastic CP have altered muscle-tendon mechanical properties. The adaptation of a longer</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Achilles tendon may facilitate a greater storage and recovery of elastic energy and partially compensate for</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">decreased force and work production by the small muscles of the triceps surae during activities such as locomotion.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Copyright © 2012 Elsevier Ltd. All rights reserved.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #009400;">PMID: 22867763 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">7. J Neurol. 2012 Aug 10. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">Botulinum toxin therapy: its use for neurological disorders of the autonomic nervous system.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Dressler D.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Movement Disorders Section, Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Hannover, Germany, dressler.dirk@mh-hannover.de.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Botulinum toxin (BoNT) has gained widespread use for the treatment of overactive muscles, overactive exocrine</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">glands and, most recently, non-muscular pain conditions. Autonomic conditions treated with BoNT include</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">achalasia, gastroparesis, sphincter of Oddi spasms, and unspecific esophageal spasms in gastroenterology and</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">prostate disorders in urology. BoNT&#8217;s use for autonomic conditions related to neurology includes various forms of</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">bladder dysfunction (detrusor sphincter dyssynergia, idiopathic detrusor overactivity, neurogenic detrusor</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">overactivity, urinary retention and bladder pain syndrome), pelvic floor disorders (pelvic floor spasms and anal</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">fissures), hyperhidrosis (axillary, palmar, and plantar hyperhidrosis, diffuse sweating, Frey&#8217;s syndrome) and</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">hypersalivation (hypersalivation in Parkinsonian syndromes, motor neuron disease, neuroleptic use, and cerebral</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">palsy). Hyperhidrosis, hypersalivation, some forms of bladder dysfunction and pelvic floor disorders can easily be</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">treated by neurologists. Most bladder dysfunctions require cooperation with urology departments.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #009400;">PMID: 22878428 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">8. Spine (Phila Pa 1976). 2012 Aug 3. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">Mortality and Morbidity in Early Onset Scoliosis Surgery.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Phillips JH, Knapp DR Jr, Herrera-Soto J.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Orlando Health-Arnold Palmer Medical Center, Pediatric Orthopaedics, 83 W. Columbia Street, Orlando, Florida</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">32806, Tel: 321.841.3060, Fax: 321.843.6304, Email: jonathan.phillips@orlandohealth.com Orlando Health-Arnold</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Palmer Medical Center, Pediatric Orthopaedics, 83 W. Columbia Street, Orlando, Florida 32806, Tel: 321.841.3060,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Fax: 321.843.6304, Email: raymond.knapp@orlandohealth.com Orlando Health-Arnold Palmer Medical Center,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Pediatric Orthopaedics, 83 W. Columbia Street, Orlando, Florida 32806, Tel: 321.841.3060, Fax: 321.843.6304,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Email: jose.herrera@orlandohealth.com.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">STRUCTURED: Study Design. Retrospective chart review. Objective. To accurately determine complication rates,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">particularly mortality rates, in surgically treated Early Onset Scoliosis. Summary of Background Data. The advent of</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">modern segmental instrumentation for spinal fusion surgery in adolescent scoliosis has allowed for application of</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">similar non-segmental un-fused techniques aimed at controlling scoliosis in the very young child. The dismal</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">prognosis for these children without repeated spinal lengthening procedures is unquestioned though no controlled</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">trials exist. Many if not most of these children need surgery, however the surgical complication rate is very high.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Methods. During the study period all surgically treated children with EOS seen at our institution were identified.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Inclusion criteria were: any patient who presented to our clinic with early onset scoliosis which was surgically</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">managed. The total number of procedures, type of implants, number and type of complications, geographic origin of</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">the cases and final outcomes were all assessed. Results. A total of 165 surgical procedures on 28 patients accrued</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ Monday 13 August 2012</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial,Bold','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">5</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">over the study time period, including index implantation of instrumentation, lengthening and definitive fusion as well</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">as operations performed for complications such as wound debridement and revision of failed implants. Clinical</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">diagnoses included congenital scoliosis, syndromic and chromosomal abnormalities, cerebral palsy and spinal</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">muscular atrophy. There was a complication rate of 84% overall with a mortality rate of almost 18%. The only</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">patients with no complications were those whose entire surgical course had been at our institution only. The</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">mortality rate was equal in patients whose treatment was performed elsewhere versus exclusively in our center.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Conclusion. This study underlines the grave severity of these scolioses particularly in syndromic children. The high</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">mortality rate is alarming, suggesting that further study is needed in this area.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #009400;">PMID: 22869061 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">9. Clin Linguist Phon. 2012 Sep;26(9):806-22.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">Relationship between kinematics, F2 slope and speech intelligibility in dysarthria due to cerebral palsy.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Rong P, Loucks T, Kim H, Hasegawa-Johnson M.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Department of Speech and Hearing Science , University of Illinois , Champaign, IL , USA.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">A multimodal approach combining acoustics, intelligibility ratings, articulography and surface electromyography was</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">used to examine the characteristics of dysarthria due to cerebral palsy (CP). CV syllables were studied by obtaining</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">the slope of F2 transition during the diphthong, tongue-jaw kinematics during the release of the onset consonant,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">and the related submental muscle activities and relating these measures to speech intelligibility. The results show</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">that larger reductions of F2 slope are correlated with lower intelligibility in CP-related dysarthria. Among the three</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">speakers with CP, the speaker with the lowest F2 slope and intelligibility showed smallest tongue release</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">movement and largest jaw opening movement. The other two speakers with CP were comparable in the amplitude</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">and velocity of tongue movements, but one speaker had abnormally prolonged jaw movement. The tongue-jaw</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">coordination pattern found in the speakers with CP could be either compensatory or subject to an incompletely</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">developed oromotor control system.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #009400;">PMID: 22876770 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - in process]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">10. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Sep;114(3):e10-4. Epub 2012 Feb 28.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">Oral myiasis: does an indication for surgical treatment still exist? Two case reports.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Ribeiro AL, de Almeida TE, Júnior JS, de Araújo Castro JF, de Jesus Viana Pinheiro J.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Professor, Department of Oral and Maxillofacial Surgery, School of Dentistry, University Center of Pará-CESUPA,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Belém, Brazil; Chairman, Department of Oral and Maxillofacial Surgery, Hospital Metropolitano de Urgência e</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Emergência, Belém, Brazil.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">OBJECTIVE: Oral myiasis is a rare infection for which treatment protocol has not yet been established. This article</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">presents 2 cases treated with a combination of topical application of sulfuric ether and surgery. The reasons for the</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">use of surgical therapy, as well as the possible advantages and disadvantages of drug-based treatments, are</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">discussed. CASE REPORT: Two cases of oral myiasis are described, the first being observed in a 9-year-old child</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">with hypotonic cerebral palsy, and the second in a 52-year-old adult, alcohol-dependant, both showing infection in</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">the gingival sulcus. Both cases were successfully treated in a process that involved topical application of sulfuric</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">ether, mechanical removal of larvae, and surgical debridement. CONCLUSIONS: Oral myiasis can be treated</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">effectively with surgery after topical application of sulfuric ether. The use of drugs may suggest a therapeutic</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">alternative, but still requires further study and experience to be implemented, especially in individuals with</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">neurological disorders.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Copyright © 2012 Elsevier Inc. All rights reserved.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #009400;">PMID: 22862986 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - in process]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ Monday 13 August 2012</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial,Bold','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">6</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">11. Int J Rehabil Res. 2012 Aug 3. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">Comparison between utility of the Thai Pediatric Quality of Life Inventory 4.0 Generic Core Scales and 3.0</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">Cerebral Palsy Module.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Tantilipikorn P, Watter P, Prasertsukdee S.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Division of Physiotherapy, School of Health and Rehabilitation Science, The University of Queensland, St Lucia,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Queensland, Australia bFaculty of Physical Therapy, Mahidol University, Salaya, Nakornprathom, Thailand.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Health-related quality of life (HRQOL) is increasingly being considered in the management of patients with various</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">conditions. HRQOL instruments can be broadly classified as generic or disease-specific measures. Several generic</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">HRQOL instruments in different languages have been developed for paediatric populations including the Pediatric</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Quality of Life Inventory 4.0 (PedsQL 4.0) Generic Core Scale. This tool and a condition-specific tool, PedsQL 3.0</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Cerebral Palsy (CP) Module, are widely used in children with CP. No psychometric properties have been reported</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">for Thai PedsQL 4.0. Therefore, this study aimed to explore the psychometric properties of the Thai version of the</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">PedsQL 4.0 Generic Core Scales and compare these with the values for the Thai PedsQL 3.0 CP Module reported</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">previously. Thai PedsQL 4.0 Generic Core Scales and the PedsQL 3.0 CP Module were completed, respectively,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">by children with CP and their parents or caregivers twice within 2-4 weeks. Respondents were 97 parents or</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">caregivers and 54 children. Minimal missing data were found in most scales. Acceptable internal consistency was</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">supported, except for Emotional, Social, and School Functioning. Intraclass correlation coefficients for parent-proxy</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">report and self-report were good to excellent (0.625-0.849). The feasibility and reliability of the Thai PedsQL 4.0</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Generic Core Scales were supported. The Thai PedsQL 3.0 CP Module showed higher values for the psychometric</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">properties. Low-to-good correlations were found among the scales between the PedsQL 4.0 Generic Core Scales</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">and the 3.0 CP Module. Both instruments could be used to measure HRQOL for children with CP, and may provide</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">different information.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #009400;">PMID: 22868944 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">12. Soc Work Health Care. 2012;51(4):279-95.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">Social workers as transition brokers: facilitating the transition from pediatric to adult medical care.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Shanske S, Arnold J, Carvalho M, Rein J.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Department of Social Work, Children&#8217;s Hospital Boston, Boston, Massachusetts 02115, USA.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">susan.shanske@childrens.harvard.edu</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Transition from pediatric to adult medical care and the significant psychosocial considerations impacting this</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">developmental process are a primary focus in health care today. Social workers are often the informal brokers of</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">this complex and nuanced process and are uniquely trained to complete biopsychosocial assessments to</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">understand the needs of patients and families and address psychosocial factors. Their extensive knowledge of</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">resources and systems, along with their sophisticated understanding of the relationship issues, family dynamics,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">cultural implications, and basic person-in-context approach allow for unique collaboration with the health care team,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">family, and community supports to develop successful transition plans and programs.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #009400;">PMID: 22489554 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - indexed for MEDLINE]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ Monday 13 August 2012</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">13. Genet Couns. 2012;23(2):215-21.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial,Bold','sans-serif'; color: black;">Pure distal 9p deletion in a female infant with cerebral palsy.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Chen CP, Lin SP, Su YN, Su JW, Chern SR, Town DD, Wang W.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Department of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei, Taiwan. cpc_mmh@yahoo.com</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">We report cytogenetic and molecular characterization of a 15.63-Mb pure distal deletion of chromosome 9p (9p22.3</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">&#8211;&gt;pter) in a l 1/2-year-old female infant with cerebral palsy and diffuse cerebral dysfunction. The deletion is of</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">paternal origin and encompasses the genes of ANKRDS15, DOCK8, FOXD4 and VLDLR. We discuss the genotype</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">-phenotype correlation in this case with neurological dysfunction and a distal 9p deletion of paternal origin.</span></p>
<p class="MsoNormal"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #009400;">PMID: 22876580 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - in process]</span></p>
</div>
<p>Go to Previous message | Go to Next message | Back to Messages<br />
| Full Headers<br />
Reply Reply All Forward Forward</p>
<p>&nbsp;</p>
<p>Mail Search<br />
WelcomeInboxNewFoldersMail Options</p>
<p>Copyright © 1994-2012 Yahoo! Inc. All rights reserved. Terms of Service &#8211; Copyright/IP Policy &#8211; Guidelines<br />
NOTICE: We collect personal information on this site.<br />
To learn more about how we use your information, see our Privacy Policy &#8211; About Our Ads.</p>
]]></content:encoded>
			<wfw:commentRss>http://cpcure.com/cerebral-palsy-the-whys-and-hows-cerebral-palsy-research/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
